Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Salestools Logo

Salestools

The #1 AI Agent for Sales teams and Go To Market teams. Sell more, faster, with less effort.

Product

  • AI Sales Agents
  • Intent Data
  • Technology Data
  • Visitor Tracking
  • Co-Pilot
  • Social Selling

Solutions

  • Customer Service
  • E-commerce
  • SaaS
  • Enterprise
  • Small Business

Resources

  • The Report
  • Documentation
  • API Reference
  • Help Center
  • Blog
  • Case Studies
  • Webinars

Company

  • About
  • Careers
  • Press
  • Contact
  • Partners

Our locations

  • New York, HQ
  • Bucharest, AI Research Lab
  • Zug, Switzerland

Β© 2025 Salestools. All rights reserved.

Data Terms & SecurityPrivacy PolicyTerms of Service
All systems operational
Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Back to The Report
Fundraising

Bristol Myers Squibb

Bristol Myers Squibb Raises $140B in Public

1887
Founded
34300+
Employees
430 East 29th Street, New York, NY 10016
Updated January 1, 2024
2 min read

Quick Facts

Bristol Myers Squibb Raises $140B in Public


Bristol Myers Squibb has successfully raised $140B in a Public at a $150B valuation led by Public.


Company Overview


Bristol Myers Squibb is a Pharmaceuticals company headquartered in 430 East 29th Street, New York, NY 10016, founded in 1887 with 34300+ employees.


Pharmaceutical company


Fundraising Details


  • Amount Raised: $140B
  • Round Type: Public
  • Valuation: $150B
  • Date: 2024-01-01
  • Investors: Public

About Bristol Myers Squibb


Pharmaceutical company The company is positioned in the Pharmaceuticals sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 430 East 29th Street, New York, NY 10016
  • Founded: 1887
  • Team Size: 34300+
  • Industry: Pharmaceuticals

What This Means


This funding round demonstrates strong investor confidence in Bristol Myers Squibb's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Pharmaceuticals sector continues to attract significant investment as companies innovate to meet evolving market demands. Bristol Myers Squibb's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $150B valuation marks an important milestone for Bristol Myers Squibb, positioning the company among notable players in the Pharmaceuticals industry.


Looking Ahead


With this new capital, Bristol Myers Squibb is well-positioned to execute on its growth strategy and continue building innovative solutions in the Pharmaceuticals space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-01-01. For more information about Bristol Myers Squibb, visit their headquarters at 430 East 29th Street, New York, NY 10016.

Topics

Fundraising(2912)Public(771)PharmaceuticalsBristol Myers Squibb

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min readβ€’160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min readβ€’130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min readβ€’120 million